179 related articles for article (PubMed ID: 31974431)
1. In silico Design of a Multivalent Vaccine Against Candida albicans.
Tarang S; Kesherwani V; LaTendresse B; Lindgren L; Rocha-Sanchez SM; Weston MD
Sci Rep; 2020 Jan; 10(1):1066. PubMed ID: 31974431
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with Secreted Aspartyl Proteinase 2 Protein from
Shukla M; Rohatgi S
Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32661125
[TBL] [Abstract][Full Text] [Related]
3. Epitope-Based Peptide Vaccine Design against Fructose Bisphosphate Aldolase of
Elamin Elhasan LM; Hassan MB; Elhassan RM; Abdelrhman FA; Salih EA; Ibrahim H A; Mohamed AA; Osman HS; Khalil MSM; Alsafi AA; Idris AB; Hassan MA
J Immunol Res; 2021; 2021():8280925. PubMed ID: 34036109
[TBL] [Abstract][Full Text] [Related]
4. A novel Th cell epitope of Candida albicans mediates protection from fungal infection.
Bär E; Gladiator A; Bastidas S; Roschitzki B; Acha-Orbea H; Oxenius A; LeibundGut-Landmann S
J Immunol; 2012 Jun; 188(11):5636-43. PubMed ID: 22529294
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Mdh1 protein as an antigenic candidate for a vaccine against candidiasis.
Shibasaki S; Aoki W; Nomura T; Karasaki M; Sewaki T; Ueda M
Biocontrol Sci; 2014; 19(1):51-5. PubMed ID: 24670619
[TBL] [Abstract][Full Text] [Related]
6. The anti-Candida albicans vaccine composed of the recombinant N terminus of Als1p reduces fungal burden and improves survival in both immunocompetent and immunocompromised mice.
Spellberg BJ; Ibrahim AS; Avenissian V; Filler SG; Myers CL; Fu Y; Edwards JE
Infect Immun; 2005 Sep; 73(9):6191-3. PubMed ID: 16113347
[TBL] [Abstract][Full Text] [Related]
7. Protective antigens and mechanisms of anti-Candida immunity.
Antonio C
Nihon Ishinkin Gakkai Zasshi; 2000; 41(4):219. PubMed ID: 11064318
[TBL] [Abstract][Full Text] [Related]
8. Saccharomyces as a vaccine against systemic candidiasis.
Liu M; Clemons KV; Johansen ME; Martinez M; Chen V; Stevens DA
Immunol Invest; 2012; 41(8):847-55. PubMed ID: 22686468
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis.
Saville SP; Lazzell AL; Chaturvedi AK; Monteagudo C; Lopez-Ribot JL
Clin Vaccine Immunol; 2009 Mar; 16(3):430-2. PubMed ID: 19144791
[TBL] [Abstract][Full Text] [Related]
10. Design of a mimotope-peptide based double epitope vaccine against disseminated candidiasis.
Xin H; Glee P; Adams A; Mohiuddin F; Eberle K
Vaccine; 2019 Apr; 37(18):2430-2438. PubMed ID: 30930005
[TBL] [Abstract][Full Text] [Related]
11. Epitope-Based Immunoinformatic Approach on Heat Shock 70 kDa Protein Complex of
Elhassan RM; Alsony NM; Othman KM; Izz-Aldin DT; Alhaj TA; Ali AA; Abashir LA; Ahmed OH; Hassan MA
J Immunol Res; 2021; 2021():9921620. PubMed ID: 34471644
[TBL] [Abstract][Full Text] [Related]
12. Phage vaccines displaying YGKDVKDLFDYAQE epitope induce protection against systemic candidiasis in mouse model.
Shi H; Dong S; Zhang X; Chen X; Gao X; Wang L
Vaccine; 2018 Sep; 36(38):5717-5724. PubMed ID: 30111514
[TBL] [Abstract][Full Text] [Related]
13. An oral vaccine against candidiasis generated by a yeast molecular display system.
Shibasaki S; Aoki W; Nomura T; Miyoshi A; Tafuku S; Sewaki T; Ueda M
Pathog Dis; 2013 Dec; 69(3):262-8. PubMed ID: 23873745
[TBL] [Abstract][Full Text] [Related]
14. Testing Antifungal Vaccines in an Animal Model of Invasive Candidiasis and in Human Mucosal Candidiasis.
Segal E
Methods Mol Biol; 2017; 1625():343-353. PubMed ID: 28585001
[TBL] [Abstract][Full Text] [Related]
15. Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice.
Li Wq; Hu Xc; Zhang X; Ge Y; Zhao S; Hu Y; Ashman RB
Vaccine; 2011 Jul; 29(33):5526-33. PubMed ID: 21645574
[TBL] [Abstract][Full Text] [Related]
16. Hybrid phage displaying SLAQVKYTSASSI induces protection against Candida albicans challenge in BALB/c mice.
Wang Y; Su Q; Dong S; Shi H; Gao X; Wang L
Hum Vaccin Immunother; 2014; 10(4):1057-63. PubMed ID: 24448202
[TBL] [Abstract][Full Text] [Related]
17. Escheriosome mediated cytosolic delivery of Candida albicans cytosolic proteins induces enhanced cytotoxic T lymphocyte response and protective immunity.
Chauhan A; Swaleha Z; Ahmad N; Farazuddin M; Vasco A; Abida M; Mohammad O
Vaccine; 2011 Jul; 29(33):5424-33. PubMed ID: 21645572
[TBL] [Abstract][Full Text] [Related]
18. Active immunizations with peptide-DC vaccines and passive transfer with antibodies protect neutropenic mice against disseminated candidiasis.
Xin H
Vaccine; 2016 Jan; 34(2):245-251. PubMed ID: 26620842
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and protective effect of recombinant enolase of Candida albicans in a murine model of systemic candidiasis.
Montagnoli C; Sandini S; Bacci A; Romani L; La Valle R
Med Mycol; 2004 Aug; 42(4):319-24. PubMed ID: 15473356
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and efficacy of CNA25 as a potential whole-cell vaccine against systemic candidiasis.
Sahu SR; Dutta A; Peroumal D; Kumari P; Utakalaja BG; Patel SK; Acharya N
EMBO Mol Med; 2024 Jun; 16(6):1254-1283. PubMed ID: 38783167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
